BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 15, 2003
View Archived Issues
Built To Last' Reata Taking Aim At Cancer, Neurological Diseases
Read More
Immune Response Adds Cash, Raises $12M For HIV Vaccines
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
CoTherix Acquires Schering's U.S. Rights For Ventavis, Raises $55M
The company formerly known as Exhale Therapeutics Inc. has acquired a new name, a new financing and new U.S. rights to a pulmonary hypertension product. (BioWorld Today)
Read More
Dyax To Receive $35M Through Biotage Sale To Pyrosequencing
Read More